Cargando…

P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen

Detalles Bibliográficos
Autores principales: Harada, N, Muraoka, D, Hayashi, T, Momose, F, Shiku, H, Tahara, Y, Sawada, S, Akiyoshi, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072102/
http://dx.doi.org/10.1186/2051-1426-2-S2-P30
_version_ 1782322904543789056
author Harada, N
Muraoka, D
Hayashi, T
Momose, F
Shiku, H
Tahara, Y
Sawada, S
Akiyoshi, K
author_facet Harada, N
Muraoka, D
Hayashi, T
Momose, F
Shiku, H
Tahara, Y
Sawada, S
Akiyoshi, K
author_sort Harada, N
collection PubMed
description
format Online
Article
Text
id pubmed-4072102
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40721022014-06-27 P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen Harada, N Muraoka, D Hayashi, T Momose, F Shiku, H Tahara, Y Sawada, S Akiyoshi, K J Immunother Cancer Poster Presentation BioMed Central 2014-03-12 /pmc/articles/PMC4072102/ http://dx.doi.org/10.1186/2051-1426-2-S2-P30 Text en Copyright © 2014 Harada et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Harada, N
Muraoka, D
Hayashi, T
Momose, F
Shiku, H
Tahara, Y
Sawada, S
Akiyoshi, K
P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
title P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
title_full P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
title_fullStr P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
title_full_unstemmed P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
title_short P56. A novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
title_sort p56. a novel cancer vaccine with nanogel-based antigen transporter and sequence-optimised long peptide antigen
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072102/
http://dx.doi.org/10.1186/2051-1426-2-S2-P30
work_keys_str_mv AT haradan p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen
AT muraokad p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen
AT hayashit p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen
AT momosef p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen
AT shikuh p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen
AT taharay p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen
AT sawadas p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen
AT akiyoshik p56anovelcancervaccinewithnanogelbasedantigentransporterandsequenceoptimisedlongpeptideantigen